Vaccine maker Bharat Biotech International Ltd (BBIL) has set up India’s only vertically integrated, purpose-designed Cell & Gene Therapy (C>) Infrastructure & Viral Vector Production facility in Genome Valley here with an investment of $75 million.
“With this, we are moving beyond vaccine innovation to leading-edge regenerative and personalised therapies that promise hope for millions,’‘ Krishan Ella, Executive Chairman, Bharat Biotech told newspersons after the formal inauguration of the facility.